1.Optimization of fermentation conditions in shake flask of JA20-1, a VOCs-producing biocontrol bacterium and evaluation of its biocontrol effect against Botrytis cinerea of ginseng.
Yu-Ze ZHANG ; Yan-Cong HU ; Xiu-Xiu WANG ; Cong ZHANG ; Zhong-Hua QU ; Bao-Hui LU ; Xue WANG ; Jie GAO
China Journal of Chinese Materia Medica 2025;50(7):1748-1757
Bacillus mycoides JA20-1 was screened and identified as a biocontrol bacterium with a high capacity for producing volatile organic compounds(VOCs) in the laboratory. This strain had significant inhibitory effects on various postharvest disease pathogens in crops, such as Botrytis cinerea, as well as soil-borne disease pathogens in ginseng, such as Sclerotinia ginseng. In order to accelerate its industrialization process, in this study, single-factor experiments and response surface optimization methods were used. The fermentation medium and fermentation conditions in the shake flask of strain JA20-1 were systematically optimized by using cell production volume as the response variable. Meanwhile, the biocontrol effect of JA20-1 on B. cinerea of ginseng during the storage period was evaluated by using the method of fumigation in a dry dish in vitro. The results indicated that the optimal fermentation medium formulation for strain JA20-1 was as follows: 1% yeast paste, 1% soluble starch, 0.25% K_2HPO_4·3H_2O, and 0.2% NaCl. The optimal fermentation conditions in the shake flask were vaccination size of 3%, culture volume of 50 mL in a 250 mL Erlenmeyer flask, pH of 6.2, fermentation temperature of 34 ℃, shaking speed of 180 r·min~(-1), and incubation time of 18 hours. The bacteria count in the fermentation broth under these conditions reached 2.17 × 10~8 CFU·mL~(-1), which was 6.58 times higher than before. The average control efficacy of the fermentation broth on Botrytis cinerea of ginseng under in vitro fumigation reached 61.70% and 84.04% respectively, when 20 mL and 30 mL per dish were used. The research provided theoretical support and technical foundation for the development and utilization of Bacillus mycoides JA20-1 and the biocontrol of soil-borne diseases in ginseng and postharvest diseases in crops.
Botrytis/drug effects*
;
Fermentation
;
Panax/microbiology*
;
Plant Diseases/prevention & control*
;
Volatile Organic Compounds/metabolism*
;
Bacillus/physiology*
;
Pest Control, Biological/methods*
;
Biological Control Agents/metabolism*
;
Culture Media/chemistry*
2.MicroRNAs mediate therapeutic and preventive effects of natural agents in breast cancer.
Chinese Journal of Natural Medicines (English Ed.) 2016;14(12):881-887
MicroRNAs (miRNAs) are a set of non-coding small RNA molecules that play a critical role in regulation of protein coding genes in cells. MiRNAs have been extensively studied as novel biomarkers, therapeutic targets, and new drugs in various human diseases. Breast cancer is a one of the leading tumor types significantly affecting women health worldwide. Over the past decade, a number of natural agents, such as paclitaxel and curcumin, have been applied for treatment and prevention of breast cancer due to their relatively low toxicity. However, the mechanisms of action have not been completely understood. Investigation on miRNAs is able to potentially provide a novel insight into better understanding the anticancer activities of these natural products. Given that a single miRNA can target multiple genes, theoretically, those genes involved in a certain phenotype can be clustered with one or a few miRNAs. Therefore, pleiotropic activities of natural agents should be interpreted by interactions between selected miRNAs and their targets. In this review, we summarize the latest publications related to the alterations of miRNAs by two natural agents (paclitaxel and curcumin) that are currently used in intervention of breast cancer, and conclude that the mechanism involving the regulation of miRNA expression is one of the keys to understand pleiotropic activities of natural agents.
Animals
;
Antineoplastic Agents
;
administration & dosage
;
Biological Products
;
administration & dosage
;
Breast Neoplasms
;
drug therapy
;
genetics
;
metabolism
;
prevention & control
;
Curcumin
;
administration & dosage
;
Female
;
Humans
;
MicroRNAs
;
genetics
;
metabolism
;
Paclitaxel
;
administration & dosage
3.Avoiding or coping with severe hypoglycemia in patients with type 2 diabetes.
The Korean Journal of Internal Medicine 2015;30(1):6-16
Hypoglycemia is a major barrier to achieving the glycemic goal in patients with type 2 diabetes. In particular, severe hypoglycemia, which is defined as an event that requires the assistance of another person to actively administer carbohydrates, glucagon, or take other corrective actions, is a serious clinical concern in patients with diabetes. If severe hypoglycemia is not managed promptly, it can be life threatening. Hypoglycemia-associated autonomic failure (HAAF) is the main pathogenic mechanism behind severe hypoglycemia. Defective glucose counter-regulation (altered insulin secretion, glucagon secretion, and an attenuated increase in epinephrine during hypoglycemia) and a lack of awareness regarding hypoglycemia (attenuated sympathoadrenal activity) are common components of HAAF in patients with diabetes. There is considerable evidence that hypoglycemia is an independent risk factor for cardiovascular disease. In addition, hypoglycemia has a significant influence on the quality of life of patients with diabetes. To prevent hypoglycemic events, the setting of glycemic goals should be individualized, particularly in elderly individuals or patients with complicated or advanced type 2 diabetes. Patients at high-risk for the future development of severe hypoglycemia should be selected carefully, and intensive education with reinforcement should be implemented.
Autonomic Nervous System/physiopathology
;
Biological Markers/blood
;
Blood Glucose/*drug effects/metabolism
;
Diabetes Mellitus, Type 2/blood/complications/diagnosis/*drug therapy/physiopathology
;
Health Knowledge, Attitudes, Practice
;
Humans
;
Hypoglycemia/blood/chemically induced/epidemiology/physiopathology/*prevention & control
;
Hypoglycemic Agents/*adverse effects
;
Incidence
;
Patient Education as Topic
;
Prevalence
;
Prognosis
;
Risk Assessment
;
Risk Factors
4.Influence of Infliximab on Cytokines Network and Markers of Bone Remodeling in Rheumatoid Arthritis Patients.
Izabela KORCZOWSKA ; Jan Krzysztof LACKI ; Pawel HRYCAJ
Yonsei Medical Journal 2013;54(1):183-188
PURPOSE: Our aim was to determine the effects of infliximab on bone mineral metabolism in rheumatoid arthritis (RA) patients and analyze the relationship between inflammatory markers of acute phase thought to play a major role in bone remodeling. MATERIALS AND METHODS: 36 patients with established RA were investigated. All patients underwent physical examination and blood and urinary analysis at baseline, 2 weeks, 14 weeks, 6 months and 12 months after the initiation of treatment. The serum levels of: tumor necrosis factor alpha (TNF-alpha), tumor necrosis factor alpha receptor 1 (TNFR1), TNFR2, interleukin 6 (IL-6), IL-17, IL-23 and markers of bone remodeling such as osteocalcin (BGP), deoxypyridynoline (Dpd), and N-telopeptide of type I collagen (NTx) were measured by ELISA. RESULTS: The results showed significant decrease of all the above cytokines levels in RA patients in comparison with those after 2 weeks of treatment. After 6 months, the markers of bone formation and resorption decreased compared to baseline values. We found positive correlation between the levels of NTx and the levels of IL-6, IL-17 and TNFR1, and between the levels of Dpd and IL-6 and Dpd and TNFR2, whereas negative correlation between BGP and IL-23. After 12 months the positive association was found at the BGP level and IL-6 as well as Dpd and the level of IL-6. We also observed a positive relation between Dpd and TNF-alpha and negative between BGP and TNFR1. CONCLUSION: We suggest that infliximab treatment may limit the risk of osteoporosis in RA patients.
Adult
;
Aged
;
Antibodies, Monoclonal/*therapeutic use
;
Antirheumatic Agents/therapeutic use
;
Arthritis, Rheumatoid/blood/complications/*drug therapy
;
Biological Markers/metabolism
;
Bone Remodeling/*drug effects
;
Bone Resorption
;
Cytokines/*metabolism
;
Female
;
*Gene Expression Regulation
;
Humans
;
Interleukin-17/metabolism
;
Interleukin-6/metabolism
;
Middle Aged
;
Osteoporosis/complications/prevention & control
;
Receptors, Tumor Necrosis Factor, Type I/metabolism
5.Neuroprotective effects of Vitis vinifera extract on prediabetic mice induced by a high-fat diet.
Heung Yong JIN ; Youn Soo CHA ; Hong Sun BAEK ; Tae Sun PARK
The Korean Journal of Internal Medicine 2013;28(5):579-586
BACKGROUND/AIMS: Vitis vinifera grape seed extract (VVE) contains oligomeric proanthocyanidins that show antioxidant and free radical-scavenging activities. We evaluated VVE for its neuroprotective effect in prediabetic mice induce by a high-fat diet (HD). METHODS: Mice were divided into four groups according to VVE dose: those fed a normal diet (ND; n = 10), HD (n = 10), HD with 100 mg/kg VVE (n = 10), and HD with 250 mg/kg VVE (n = 10). After 12 weeks, immunohistochemical analyses were carried out using a polyclonal antibody against antiprotein gene product 9.5 (protein-gene-product, 9.5), and intraepidermal innervation was subsequently quantified as nerve fiber abundance per unit length of epidermis (intraepidermal nerve fiber, IENF/mm). RESULTS: Daily administration of VVE at doses of 100 or 250 mg/kg for 12 weeks protected HD mice from nerve fiber loss compared to untreated mice, as follows (IENF/mm): controls (40.95 +/- 5.40), HD (28.70 +/- 6.37), HD with 100 mg/kg (41.14 +/- 1.12), and HD with 250 mg/kg (48.98 +/- 7.01; p < 0.05, HD with VVE vs. HD). CONCLUSIONS: This study provides scientific support for the therapeutic potential of VVE in peripheral neuropathy in an HD mouse model. Our results suggest that VVE could play a role in the management of peripheral neuropathy, similar to other antioxidants known to be beneficial for diabetic peripheral neuropathy.
Animals
;
Antioxidants/*pharmacology
;
Biological Markers/blood
;
Blood Glucose/drug effects/metabolism
;
Body Weight/drug effects
;
Diabetic Neuropathies/blood/etiology/pathology/*prevention & control
;
*Diet, High-Fat
;
Disease Models, Animal
;
Dose-Response Relationship, Drug
;
Epidermis/*innervation
;
Grape Seed Extract/*pharmacology
;
Lipids/blood
;
Male
;
Mice
;
Mice, Inbred C57BL
;
Neuroprotective Agents/*pharmacology
;
Peripheral Nerves/*drug effects/pathology
;
Phytotherapy
;
Plants, Medicinal
;
Prediabetic State/blood/*drug therapy/etiology
;
Time Factors
;
*Vitis
6.Agglutinated activity bioassay method for the determination of antivirus potency of Banlangen granula.
Hui-Ying TANG ; Dan YAN ; Shao-Feng ZHANG ; Han-Bing LI ; Rong-Hua LIU ; Xiao-He XIAO
Acta Pharmaceutica Sinica 2010;45(4):479-483
To establish a bioassay method and quality standard of Banlangen granula, agglutinated activity assay was used in the analysis of the traditional Chinese medicine, Banlangen granula. It showed that masculined effect could be picked up effectively and the products quality of different pharmaceutical factories and different batch numbers from the same factory could be revealed conveniently, accurately, quickly and directly with this method (valence value was between 2 and 11). The established bioassay method had a good reproducibility with RSD = 2%. The dependablity of the activity of red cell agglutination and restrainting influenza virus NA was conspicuous (r2 = 0.878 3). In conclusion, this bioassay method is suitable to control and evaluate the quality of Banlangen granula. Thus the method may provide a simple and effective technique in supervising and examining the quality of other traditional Chinese medicine.
Animals
;
Antiviral Agents
;
administration & dosage
;
isolation & purification
;
pharmacology
;
standards
;
Biological Assay
;
Dosage Forms
;
Drugs, Chinese Herbal
;
administration & dosage
;
isolation & purification
;
pharmacology
;
standards
;
Hemagglutination
;
drug effects
;
Male
;
Neuraminidase
;
metabolism
;
Orthomyxoviridae
;
drug effects
;
enzymology
;
Plants, Medicinal
;
chemistry
;
Quality Control
;
Rabbits
;
Reproducibility of Results
7.Biological evaluation of Radix Isatidis based on neuraminidase activity assay.
Han-Bing LI ; Dan YAN ; Jia-Bo WANG ; Jing-Yan WANG ; Zhu-Chun BEI ; Li WEI ; Xiao-He XIAO
Acta Pharmaceutica Sinica 2009;44(2):162-166
Radix Isatidis (Banlangen in Chinese) is a traditional Chinese medicinal (TCM) herb, and is frequently used for treating influenza. However, the current quality control method for Radix Isatidis should be developed since it has little correlation to the pharmacodynamic action. In this paper, the in vitro inhibitory action of Radix Isatidis on neuraminidase (NA) was investigated by fluorometric assay with 4-methylumbelliferyl-D-N-acetylneuraminate (FL-MU-NANA) method. Based on the method, the experimental condition was optimized and a bioassay statistic method was established according to the reaction type and the regularity of "parallel lines of qualitative effect". Then the bioassay method of Radix Isatidis was established. This study indicated that Radix Isatidis had obvious in vitro inhibitory activity on NA with IC50 = (0.90 +/- 0.20) mg x mL(-1) (herb). The correlation between logarithmic dose and reaction rate showed an "S" shape--is quite similar to Tamiflu's reaction curve, which hinted that Radix Isatidis had the same inhibitory function on NA as Tamiflu. The established bioassay method of "parallel lines of qualitative effect" had a good reproducibility (RSD = 5.78%). The results of potency determination of Radix Isatidis were reliable (reliability test: deviation from straight line P > 0.05, deviation from parallel line P > 0.05) and well regular. As a conclusion, this bioassay method is suitable to control and evaluate the quality of Radix Isatidis.
Animals
;
Antiviral Agents
;
isolation & purification
;
pharmacology
;
Biological Assay
;
Cell Line
;
Dogs
;
Drugs, Chinese Herbal
;
isolation & purification
;
pharmacology
;
Influenza A virus
;
enzymology
;
Inhibitory Concentration 50
;
Isatis
;
chemistry
;
Kidney
;
cytology
;
enzymology
;
virology
;
Neuraminidase
;
metabolism
;
Oseltamivir
;
pharmacology
;
Plant Roots
;
chemistry
;
Plants, Medicinal
;
chemistry
;
Quality Control
;
Reproducibility of Results
;
Structure-Activity Relationship
8.Establishment of reporter gene-based cell screening model for discovering new chemopreventive agents.
Hairong XU ; Ping BU ; Xiangming LI
China Journal of Chinese Materia Medica 2009;34(14):1835-1839
OBJECTIVETo discover new chemopreventive agents, a drug screening cell model based on reporter gene and antioxidative response element (ARE) has been established.
METHODFour repeas of ARE DNA binding conserved sequences were synthesized and cloned into a GFP expression vector. This construct was stably transfected into HepG2 cells in vitro. The cell model was tested with known chemopreventive agents and the effects of resveratrol, protocatechuic aldehyde, ursolic acid and oleanolic acid at different concentration (0, 12.5, 25, 50, 100, 200 micromol x L(-1)) were observed by determining reporter gene GFP activity.
RESULTThe induce level of GFP was regulated by ARE and the dose-dependence in a certain range was observed. The induce level of GFP by resveratrol was significantly increased.
CONCLUSIONThe method can be used to screening of chemopreventive agents from Chinese traditional medicine by measurement of luminescent value of expressed GFP in wells of microtiter plate.
Antineoplastic Agents ; pharmacology ; Chemoprevention ; Drug Screening Assays, Antitumor ; methods ; Drugs, Chinese Herbal ; pharmacology ; Gene Expression ; drug effects ; Genes, Reporter ; drug effects ; Green Fluorescent Proteins ; genetics ; metabolism ; Hep G2 Cells ; Humans ; Models, Biological ; Neoplasms ; drug therapy ; prevention & control
9.The mechanisms of brain ischemic insult and potential protective interventions.
Zhao-Hui GUO ; Feng LI ; Wei-Zhi WANG
Neuroscience Bulletin 2009;25(3):139-152
The mechanisms of brain ischemic insult include glutamate excitoxicity, calcium toxicity, free radicals, nitric oxide, inflammatory reactions, as well as dysfunctions of endoplasmic reticulum and mitochondrion. These injury cascades are interconnected in complex ways, thus it is hard to compare their pathogenic importances in ischemia models. And the research in cellular and molecular pathways has spurred the studies in potential neuroprotections mainly in pharmacological fields, such as anti-excitotoxic treatment, calcium-channel antagonism, approaches for inhibition of oxidation, inflammation and apoptosis, etc. Besides, other protective interventions including thrombolysis, arteriogenesis, regeneration therapy, and ischemia preconditioning or postconditioning, are also under investigations. Despite the present difficulties, we are quite optimistic towards future clinical applications of neuroprotective agents, by optimizing experimental approaches and clinical trials.
Animals
;
Brain Ischemia
;
metabolism
;
physiopathology
;
prevention & control
;
Humans
;
Models, Biological
;
Neuroprotective Agents
;
pharmacology
;
Signal Transduction
;
drug effects
;
physiology
10.Inhibition of excitatory amino acid efflux contributes to protective effects of puerarin against cerebral ischemia in rats.
Xiao-Hong XU ; Xiao-Xiang ZHENG ; Qiong ZHOU ; Hui LI
Biomedical and Environmental Sciences 2007;20(4):336-342
OBJECTIVETo investigate whether the protective effects of puerarine (Pur) against cerebral ischemia is associated with depressing the extracellular levels of amino acid transmitters in brain of rats.
METHODSMale Sprague-Dawley rats were subjected to transient middle cerebral artery occlusion (MCAO) for 60 min followed by 24 h reperfusion. Pur (50, 100 mg/kg, i.p.) was administered at the onset of MCAO. The infarct rate and edema rate were detected on TTC (2,3,5-triphenyltetrazolium chloride)-stained coronal sections. The extracellular levels of amino acid transmitters were monitored in striatum of rats with ischemic/reperfusion injury using in vivo microdialysis technique. Furthermore, the protective effects of Pur against glutamate-induced neurotoxicity were detected. Glutamate-induced apoptotic and necrotic cells in hippocampus were estimated by flow cytometric analysis of Annexin-V and PI labeling cells.
RESULTSPur (100 mg/kg) significantly decreased infarct size by 31.6% (P<0.05), reduced edema volume (P<0.05), and improved neurological functions (P<0.05) following MCAO. In these rats, the ischemia-induced extracellular levels of aspartate (Asp), glutamate (Glu), y-aminobutyric acid (GABA), and taurine (Tau) were significantly reduced in striatum of vehicle-treated animals by 54.7%, 56.7%, 75.8%, and 68.1% (P<0.01 and P<0.05). Pur reduced the peak values of Glu and Asp more obviously than those of GABA and Tau, and the rate of Glu/GABA during MCAO markedly decreased in Pur-treated MCAO rats, compared with the vehicle-treated MCAO rats. Meanwhile, apoptosis and necrosis induced by Glu in cultured hippocampal neurons were significantly reduced after Pur treatment.
CONCLUSIONAcute treatment with Pur at the onset of occlusion significantly depresses ischemia-induced efflux of amino acids, especially, excitotoxicity in the striatum, a mechanism underlying the neuroprotective effect on cellular survival.
Animals ; Biological Transport ; Brain Ischemia ; pathology ; prevention & control ; Excitatory Amino Acids ; metabolism ; Flow Cytometry ; Hippocampus ; drug effects ; pathology ; Isoflavones ; pharmacology ; Male ; Microdialysis ; Neuroprotective Agents ; pharmacology ; Rats ; Rats, Sprague-Dawley

Result Analysis
Print
Save
E-mail